Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-03

Clinical Trial Update: Aleeto in Acute ISchemic Stroke:A RandomISed Controlled Clinical Trial [Phase 2]

View source ↗

Summary

A Phase 2 randomized controlled trial evaluating Aleeto for acute ischemic stroke, currently recruiting at Beijing Tiantan Hospital.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aleeto

Snippet

Sponsor: Beijing Tiantan Hospital | Conditions: Acute Ischemic Stroke | Phase 2 | Status: RECRUITING